Retail Pharmacist Grew 13.1% in 2016

According to a survey conducted by Interfarma (Association of research-based pharmaceutical industry), with data from IMS Health, the Brazilian pharmaceutical industry obtained an increase of 13.1% in the past year towards 2015. The turnover was 85.35 R$ billion against R$ 75.49 billion the previous year, taking into account the list price for medicines, without considering any discounts from pharmacies. The same indices were checked for drugs that require a prescription and other products. Generic drugs already had growth of 14.7% and represent 26.6% of the market.
Painkillers Were the most Sold according to the survey, the first class of appears "Narcotic Painkillers and antipyretics" with revenues of 3.82 billion R$ (4.5%). Then appear the classes "antidepressants and mood stabilizers" and "regulatory preparations of cholesterol and triglycerides," with sales of 3.45 billion R$ and R$ 3.02 billion, respectively. The top ten pharmaceutical groups did together R$ 48.59 billion in 2016, accounting for 56.9% of the retail market. The top ten therapeutic classes were responsible for the revenues of 27.49 billion R$, corresponding to 32.2% of the retail market.